Renal Ca Flashcards

(55 cards)

1
Q

Risk factors of rcc

A
Tobacco
Obesity
Hypertension
Esrd with acquired cystic ds
Hereditary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mc type of RCC

A
CLEAR CELL%75- prox tubule 
Papillary 15 prox tub
Chrome phobe
Oncocytoma 5 each from distal 
Collecting duct less than 1 %
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many pt undergoing dialysis develop acquired cystic disease kidney

A

40-50%

5.8% of those cysts dvelop rcc mc papillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which familial rcc aw clear cell histology

A
Vhl-3p ✅
Hereditary papillary rcc 7q
Hereditary leiomyomatosis rcc 1q
Birt hogg dube 17p11
Sdh ✅
TSC9q 16p
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

C met gene asso with

A

Hprc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which rcc affects m=f with excellent prognosis

A

Chromophobe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rcc mc in women

A

Mucinous tubular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sundrome with uterine fibroids early pmset
Adtenal hyperplasia
Kidney cancer

A

Hlrcc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

.Immuno PET using antibody against carbonic

anhydrase IX is useful in which subtype of RCC

A

Clear cell and papillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Esrd which yr sceening start

A

3 yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bap1 tumor aw

A

Clear cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Melanoma and hif1

A

MiTF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Screening-Rcc

A

Vhl and hlrcc

From 16 yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HGF aw

A

Papillary type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Xp RCC

A

Papillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rcc in cowden

A

Papillary
Pten
Killin mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many ct enhancing lesions are benign-rcc

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Plant cells seen in

A

Chromophobe
Positive hales colloid iron stain
CK7 esinophilic subtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Plant cell

A

Chromophobe

Positive hales colloid iron stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hyper vascular tumors

A

Clear cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Multicentric rcc

A

Papillry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Best prognosis

A

Papilary 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mc paraneoplastic

24
Q

Stauffers syndrome whats elevated

25
Absolute ci for cytoreductive nephrectomy
Brain mets Poor performanxe status Relative- non clear cell
26
Mskcc prognostic system
``` Low karnofsky High ldh Low hb High ca Time from dx to tt less than 1 yr ```
27
Imdc
``` Low karnofsky Low hb High ca Time les than 1 yr High neutro High platelet ```
28
Radical mephrectomy
Robson
29
Partial nephrectomy normal percentage left behind in solitary
20-30%
30
Prevalence of ln mets on rcc
6%
31
Partial nephrectomy indication
``` Indication • Small unilateral tumors (Tia, selected Tib) • Tumor in • Uninephric state • Renal insufficiency • Familial tumor • Bilateral tumor Note- Tra-*tumor 4cm or less limited to kidney Tib > tumor >4cm but not >7cm limited to kidney Stage I > T1 NO MO Renal vein thrombus not a ci ```
32
Local recurrence after prtial nephrectomy
3-5%
33
Surveilance after thermal ablation rcc
Annual cxr 6 m mri 3 m ct
34
• In Small incidentally diagnosed renal tumours what percentage of tumours will have zero radiographic growth in 36 months
30%
35
Linear volumetric growth of radiologically localised small rcc
0.3cm per yr
36
Surveillance size cut of
Solid tumors 2 cm Cystic 4 cm Familial 3 cm
37
Highest response chemo in mets rcc
Lenvatenib
38
Pref drug for clear cell
Axitinib + pembrolizumab • Cabozantinib + nivolumab • lenvatinib + pembrolizumab®
39
Pref regime for nonclear cell
Cabozantinib | Sunitinib
40
Maligannt features in ivu
Calcification within the mass •increased tissue densit • Irregular margins • Distortion of collecting system
41
Hu less than 20 solid mass negative attenuation
Aml
42
Rcc if contrast more than hu?
15
43
Sestamini pet used in which rcc
Chromophobe
44
Radical nephrect criteria
, RN is preferred if all of the following criteria are met: (1) high tumor complexity and PN would be challenging even in experienced hands; (2) no preexisting chronic kidney disease (CKD) or proteinuria; and (3) normal contralateral kidney and new baseline estimated glomerular filtration rate (eGFR) will likely de >45 mL/min/1.73 m2
45
Ariser trial Everest trial Prosper trial Immotion trial
Girentuximab Everolimus Nivolumab Atezolilumab
46
Carmena | Surtime trial
Targeted therapy sunitinib and cytoreductive nephrectomy
47
Uiss
Tnm Performance Tr grade
48
Mc tumor mets to kidney is from
Lung
49
Chemo indicated in rcc
Chromophobe and medullary Carbo gemcit Paclicarbo
50
Genetic screening indication in rcc
``` Dx les than or eq 46 yrs Bil or multifocal tr One or more first or second degree relative with rcc Histology - multifocal papillary Hlrcc Bhd Aml tsc Sdh ```
51
Everolimus prophylaxis
Aml tsc more than 3 cm
52
Tumor ablation highest for
Posterior lesions
53
Tumor venous thrombus levels in rcc
``` 0- renal vein 1- ivc less than 2 cm above rv 2- more than 2 cm but below hep vein 3- to or above hep v but below diaphragm 4- above diaphragm ```
54
Ln d done in rcc ?
Children or young adults
55
Markers of rcc
Cc rcc- ca 9 | Aquaporin1 and perilipin 2